Need professional-grade analysis? Visit stockanalysis.com
N/A
N/A
28
N/A
Price Chart
Also Listed On
Calidi Biotherapeutics, Inc. (CLDWW) Price Performance
Calidi Biotherapeutics, Inc. (CLDWW) trades on United States in USD. The company is classified in the Healthcare sector under the Biological Products industry. The stock currently trades at $0.01.
Over the past year, CLDWW has traded between a low of $0.00 and a high of $0.03. The stock has lost 23.1% over this period. It is currently 80.0% below its 52-week high.
About Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcinoma, and soft tissue sarcoma, which is in pre-clinical studies; CLD-301 for multiple indications, which is in preclinical studies; and CLD-400 for certain lung cancer and metastatic solid tumors. The company also offers oncolytic virus platforms, such as NeuroNova, SuperNova, and RTNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
Company Info
- Sector
- Healthcare
- Industry
- Biological Products
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- N/A
- EBITDA
- N/A
- Profit Margin
- N/A
- EPS (TTM)
- N/A
- Book Value
- 1.53
Technical Indicators
- 52 Week High
- $0.03
- 52 Week Low
- $0.00
- 50 Day MA
- N/A
- 200 Day MA
- N/A
- Beta
- N/A
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- N/A
- Price/Book
- N/A
- Enterprise Value
- N/A